Testing effectiveness (Phase 2)Study completedNCT02250508
What this trial is testing
Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.
Who this might be right for
vonWillebrand's Disease
Bio Products Laboratory